Login

freedom and sense of ownership led to a golden period of creativity|Jeff Jordan,General Partner,Andreessen Horowitz 00:10:00

Share On Facebook Share On Twitter

Jeff was previously CEO and then executive chairman of OpenTable, where he led the company during a period of accelerated domestic and international growth and oversaw its initial public offering during one of the longest tech IPO droughts in recent history. Prior to OpenTable, Jeff was Senior Vice President and General Manager of eBay North America where he oversaw eBay's early growth into one of the Internet's leading commerce brands.

Recent Videos

00:10:00
Thomas Olin Highlights Kancera’s Latest Advances and Strategic Focus | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Pablo Pereiro Discusses Squirrel Media’s 63% Profit Growth and 14.7% Stock Surge | Pablo Pereiro , CEO , Squirrel Media SA.
00:10:00
Steve Oliver of musicMagpie Discusses Circular Economy and Company's Growth Strategy | Steve Oliver , CEO , musicMagpie PLC.
00:10:00
Revolutionizing Healing with Naturally Derived Psychedelics | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
SMC Global Securities Launches New Office at Bahu Plaza, Jammu, to Promote Share Market Investments | Ajay Garg , CEO , SMC Global Securities Ltd.
00:10:00
Exploring Demoralization Syndrome Treatment with Filament Health’s Psilocybin Trials | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
BioInvent CEO Explores Portfolio Strategy and Upcoming Breakthroughs | Dr. Martin Welschof, CEO , BioInvent International AB.
00:10:00
Piotr Figarski Discusses Image Power's 2022 Results and Future Trends | Piotr Figarski, Vice President , Image Power SA.
00:10:00
Pablo Pereiro and María Bonaria Fois Discuss Squirrel Media's Strategic Acquisition of Mondo TV Studios | Pablo Pereiro , CEO , Squirrel Media SA.
00:10:00
Lexington Gold Set to List on London AIM Exchange After Reverse Takeover | Dr. Bernard Olivier, CEO , Lexington Gold Ltd.
00:10:00
Thomas Olin, CEO of Kancera AB, Discusses Strategic Advances in Biopharma Innovation | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Leading the Charge in the Psychedelic Movement with Filament Health | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
Pini Mandel on the Power of Dynamic Pricing to Boost Retail KPIs and Customer Satisfaction | Pini Mandel , CEO , Quicklizard Ltd.
00:10:00
Jean Michel Ng Tseung, New CEO of MCB Group, Shares Vision for a Sustainable Future | Jean Michel Ng Tseung , CEO , MCB Group Ltd.
00:10:00
Viktor Garmiani Unveils Candles Scandinavia’s Q4 Report Highlights | Viktor Garmiani, CEO , Candles Scandinavia AB.
00:10:00
Squirrel Media's Record-Breaking Year: CEO Pablo Pereiro Discusses Key Strategies and Global Expansion | Pablo Pereiro , CEO , Squirrel Media SA.

Suggestions

00:10:00
Saudi Arabia's Expansive Mining Potential and Investor Opportunities
00:10:00
SOSVs program for startups with a hardware element|Cyril Ebersweiler,General Partner,HAX
00:10:00
The Growth Engine: A Systematic Approach to User Acquisition|Brian Balfour,Venture Partner,Long Journey Ventures
00:10:00
Dieter Sand, CEO of Arlandastad Group: Insights from Penser Access by Carnegie | Dieter Sand, CEO, Arlandastad Group AB.
00:10:00
Air France-KLM CEO Ben Smith on the Importance of EU Vaccine Certificates for the Future of Air Travel | Benjamin Smith, CEO, Air France-KLM .
00:10:00
Steve Wynn on Reinventing Las Vegas and His Journey to Success
00:10:00
Chris Barnes, CEO of Tracsis Plc, Recognized for Driving Ambition in finnCap Ambition Nation Listed 50
00:10:00
Climate Resilience Panel at Infraday Florida | Allan Marks - Partner of Milbank LLP
00:10:00
Adapting to Increased Competition and Navigating Uncertainties | Daniel Flaig, Managing Partner, Capvis Equity Partners AG.
00:10:00
Metric Point Capital: AI-Driven Investment Solutions and High-Yield Opportunities
00:10:00
"Strategies for Tax-Free Retirement Income with Bruce Hosler, CFP® | Hosler Wealth Management"
00:10:00
Innovative neuroprotective therapy ARG-007 shows promise in reducing brain cell death post-stroke, poised for phase one clinical trial |Dr Liz Dallimore , CEO, Argenica Therapeutics Ltd.

© 2017 - Townhall + Tv